# BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential

> **NCT07416500** · NA · COMPLETED · sponsor: **Institute of Oncology Ljubljana** · enrollment: 301 (actual)

## Conditions studied

- Breast Cancer
- Breast Lesions of Uncertain Malignant Potential (B3 Lesions)

## Interventions

- **DIAGNOSTIC_TEST:** MS-MLPA Methylation Analysis

## Key facts

- **NCT ID:** NCT07416500
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07416500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07416500, "BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07416500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*